Nucleic Acid Nanomaterials: Biostability and Applications

Shaojingya      Gao; YunFeng      Lin
[1]
Lin, Y. & Qian, Z. Absorption, pharmacokinetics and disposition of biodegradable nanoscale preparations. Curr Drug Metab 13,  337. (2012).
 [http://dx.doi.org/10.2174/138920012800166599]

[2]
Xie X, et al. Methods to Improve the Stability of Nucleic Acid-Based Nanomaterials. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230601091346]

[3]
Yao L, Qing H, & Zhang T. The application of nucleic acid nanomaterials in the treatment of mitochondrial dysfunction. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230614115655]

[4]
Zhang J, Li J, Sui L, & Li Y. Framework nucleic acids: a promising vehicle for small molecular cargos. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230120124402]

[5]
Zhang Q, Lin S, & Shi J. Synthesis and biomedical applications of DNA hydrogel. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230710124838]

[6]
Zhu Q, et al. Application of Nucleic Acid Nanomaterials in the Treatment of Endocrine and Metabolic Diseases. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230410111015]

[7]
Sun Y, Meng L, Zhang Y, Zhao D, & Lin Y. The Application of Nucleic Acids and Nucleic Acid Materials in Antimicrobial Research. Curr Stem Cell Res Ther  16; 66-73 (2021).
 [http://dx.doi.org/10.2174/1574888X15666200521084417]

[8]
Yao Y, Yang M, & Shi S. Nucleic Acid Nanomaterials-based Therapy for Osteoarthritis: Progress and Prospects. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230202155414]

[9]
Huang H, Gao S, Cai X. DNA-based Nanomaterials in the Immunotherapy. Curr Drug Metab  (2023).
 [http://dx.doi.org/10.2174/1389200224666230413082047]
Cite As
Current Drug Metabolism

Nucleic Acid Nanomaterials: Biostability and Applications
